CFDE Data Portal | Search LINC02610

	Label	Description
	LINC02610 Gene (Entity type)	ENSG00000186235 - long intergenic non-protein coding RNA 2610
	GSE213588 trametinib NF1 8 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 10 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE212330 azacitidine 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216540 fulvestrant 10 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE103510 STAT5 inhibition 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273 GSE216292 palbociclib 14 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE186709 GSE186711 MLL inhibition 4 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216540 fulvestrant 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE110709 GSK-J4 5 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS

LINC02610

ENSG00000186235 - long intergenic non-protein coding RNA 2610

GSE213588 trametinib NF1 8 v 11 human up

A Gene Set from LINCS

GSE100148 EZH2 inhibition 10 v 5 human dn

A Gene Set from LINCS

GSE212330 azacitidine 1 v 0 human dn

A Gene Set from LINCS

GSE216540 fulvestrant 10 v 6 human up

A Gene Set from LINCS

GSE103510 STAT5 inhibition 2 v 0 human dn

A Gene Set from LINCS

GSE216273 GSE216292 palbociclib 14 v 7 human up

A Gene Set from LINCS

GSE186709 GSE186711 MLL inhibition 4 v 6 human dn

A Gene Set from LINCS

GSE216540 fulvestrant 0 v 6 human up

A Gene Set from LINCS

GSE110709 GSK-J4 5 v 4 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.